secwatch.observer — SEC 8-K summary
======================================

Issuer:     SANGAMO THERAPEUTICS, INC (SGMO)
CIK:        0001001233
Form:       8-K
Filed at:   2023-03-02T23:59:59+00:00
Accession:  0001628280-23-006092
Event type: other_material
Sentiment:  neutral
Materiality: 0.50
Item codes: 7.01
LLM model:  deepseek-v4-flash:cloud@v2

Sangamo Therapeutics decides not to proceed with public offering; reaffirms cash runway
--------------------------------------------------------------------------------

- Sangamo explored a potential public offering but chose not to move forward after evaluating market conditions and business outlook.
- Company believes available cash, equivalents, and marketable securities will fund operations for at least 12 months from Dec 31, 2022 10-K.
- Sangamo will continue to seek additional capital, including non-dilutive sources, and may pursue equity financing in the future.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1001233/000162828023006092/0001628280-23-006092-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1001233/000162828023006092/sgmo-20230302.htm
  HTML page:      https://secwatch.observer/filing/0001628280-23-006092

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer